ProKidney Corp.
PROKHealthcare|Biotechnology|US
$1.14
+0.07 (+7.04%)
DCF Value
$0.86
Tangible Book / Share
$1.19
Cash / Share
$0.97
Clinical Trials (10)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT05099770 Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease | Type 2 Diabetes Mellitus, Chronic Kidney Diseases | P3 | Active | 685 | RCT, Double-blind | Renal Autologous Cell Therapy (REACT/ rilparencel) |
| NCT05918523 A Long-Term Follow-Up Study of Participants Exposed to REACT | Diabetic Kidney Disease, Chronic Kidney Diseases | Recruiting | 80 | — | Renal Autologous Cell Therapy (REACT) | |
| NCT05286853 A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disease | Type 2 Diabetes Mellitus, Chronic Kidney Diseases | P3 | Withdrawn | — | RCT, Double-blind | Renal Autologous Cell Therapy (REACT) |
| NCT02525263 Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD) | Chronic Kidney Disease, Type 2 Diabetes | P2 | Terminated | 1 | Open-label | Neo-Kidney Augment |
| NCT02836574 A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease | Type 2 Diabetes Mellitus, Chronic Kidney Disease | P2 | Completed | 83 | RCT, Open-label | Renal Autologous Cell Therapy (REACT) |
| NCT05018416 Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007) | Chronic Kidney Diseases, Type 1 Diabetes Mellitus | P2 | Completed | 53 | RCT, Open-label | Renal Autologous Cell Therapy (REACT) |
| NCT03270956 A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease | Type 2 Diabetes Mellitus, Chronic Kidney Disease | P2 | Completed | 10 | Open-label | Renal Autologous Cell Therapy (REACT) |
| NCT05694169 A Study of Participants With Chronic Kidney Disease Previously Treated With REACT | Diabetic Kidney Disease, CAKUT | P1 | Terminated | 1 | Open-label | Renal Autologous Cell Therapy (REACT) |
| NCT04115345 A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT). | Chronic Kidney Disease, Congenital Anomalies of Kidney and Urinary Tract | P1 | Completed | 6 | Open-label | Renal Autologous Cell Therapy (REACT) |
| NCT06790498 Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product | Diabetic Kidney Disease, Chronic Kidney Disease | By Invite | 50 | — | Renal Autologous Cell Therapy (REACT) |